Skip to content
Open Data Finder

Search results for Guidance document for industry

Filters

56 datasets for “Guidance document for industry”

  1. Open Government Canada

    Special Access Program for drugs: Guidance document for industry and practitioners

    Health Canada | Santé CanadaUpdated 29 Dec 2023

    This guidance document explains the regulatory information requirements and conditions for practitioners and manufacturers when drugs are requested …

    • HTML
  2. Open Government Canada

    Reporting adverse reactions to marketed health products - Guidance document for industry

    Health Canada | Santé CanadaUpdated 4 Apr 2024

    This guidance document provides market authorization holders (MAHs) with assistance on how to comply with the Food and …

    • HTML
  3. Open Government Canada

    Notice to stakeholders: Final guidance document for industry and practitioners on the Special Access Program (SAP) for drugs

    Health Canada | Santé CanadaUpdated 29 Oct 2023

    This document gives information on changes made to the Food and Drug Regulations. It was published on October …

    • HTML
  4. Open Government Canada

    Guidance Document for Industry - Review of Drug Brand Names

    Health Canada | Santé CanadaUpdated 7 Jul 2021

    … the potential for a proposed name to be misleading or confused with another product authorized for use in …

    • HTML
  5. Open Government Canada

    Final Guidance Document Data Requirements for Safety and Effectiveness of Steroid Nasal Products for Use in the Treatment of Allergic Rhinitis for Industry

    Health Canada | Santé CanadaUpdated 2 Dec 2023

    This guidance is intended to assist sponsors in the collection and analysis of data for Steroid Nasal products …

    • HTML
  6. Open Government Canada

    Clarification of section 4.3 (Regulatory Authority Sources) of the Reporting Adverse Reactions to Marketed Health Products - Guidance Document for Industry

    Health Canada | Santé CanadaUpdated 30 Mar 2024

    … of the May 2018 update to the Reporting Adverse Reactions to Marketed Health Products - Guidance Document for Industry.

    • HTML
  7. Open Government Canada

    Guidance For Industry Management of Regulatory Submissions

    Health Canada | Santé CanadaUpdated 8 Jul 2021

    This guidance document provides clarification to submission sponsors on how to comply with (Veterinary Drugs Directorate of Health …

    • HTML
  8. Open Government Canada

    Final Guidance Document Data Requirements for Safety and Effectiveness of Steroid Nasal Products for Use in the Treatment of Allergic Rhinitis for Industry

    Health Canada | Santé CanadaUpdated 1 Jun 2021

    This guidance is intended to assist sponsors in the collection and analysis of data for Steroid Nasal products …

    • HTML
  9. Open Government Canada

    Draft Guidance for Industry: Preparation of Comparative Bioavailability Information for Drug Submissions in the CTD Format

    Health Canada | Santé CanadaUpdated 1 Jun 2021

    The purpose of this guidance is to define the Common Technical Document (CTD) format of drug submissions which …

    • HTML
  10. Open Government Canada

    Guidance for Industry Preparation of Veterinary New Drug submissions

    Health Canada | Santé CanadaUpdated 8 Jul 2021

    This Guidance Document is to be used in the preparation of Veterinary Drug Submissions for presentation to Health …

    • HTML
  11. Open Government Canada

    Draft Guidance for Industry, Preparation of the Quality Information for Radiopharmaceuticals (Schedule C Drugs) using the Quality Information Summary-Radiopharmaceuticals (QIS-R) and Certified Product Information Document

    Health Canada | Santé CanadaUpdated 7 Jun 2022

    The purpose of this guideline is to provide sponsors of New Drug Submissions (NDSs) and related submissions (responses …

    • HTML
  12. data.gov.ie

    Radon Map for use with Technical Guidance Document - C

    Environmental Protection AgencyUpdated 13 Nov 2026

    This map shows those areas where Technical Guidance Document - C is to be used. The map is based …

    • HTML
  13. Open Government Canada

    Draft Guidance for Industry: Quality Guidance: Applications for Drug Identification Numbers (DINAs) for Pharmaceuticals

    Health Canada | Santé CanadaUpdated 3 Sept 2023

    … of Applications for Drug Identification Numbers (DINAs) for chemical entities. The purpose of the guidance document is to …

    • HTML
  14. Open Government Canada

    Preparation of the Quality Information for Drug Submissions in the CTD Format: Biotechnological/ Biological (Biotech) Products: Guidance for Industry

    Health Canada | Santé CanadaUpdated 3 Sept 2023

    This document is intended to provide Industry with guidance for the preparation of drug submissions for Biotechnological/ Biological …

    • HTML
  15. Open Government Canada

    Important regulatory considerations for the supply of medical gowns: Guidance to industry

    Health Canada | Santé CanadaUpdated 30 Jun 2021

    The purpose of this document is to provide regulatory information with regard to medical gowns.

    • HTML
  16. Open Government Canada

    Label Process Changes: Part 2: Guidance for Industry

    Health Canada | Santé CanadaUpdated 3 Aug 2021

    The purpose of this document is to provide guidance to industry on the implementation of the label process …

    • HTML
  17. Open Government Canada

    Guidance on Medical Device Compliance and Enforcement (GUI-0073)

    Health Canada | Santé CanadaUpdated 17 Sept 2020

    This document outlines the strategy and provides guidance for the medical device industry on Health Canada's compliance …

    • HTML
  18. Open Government Canada

    Guidance Document: Determining Prescription Status for Human and Veterinary Drugs

    Health Canada | Santé CanadaUpdated 7 Jul 2021

    … This document is also designed to help the public, industry and healthcare professionals, including veterinarians, as well as …

    • HTML
  19. Open Government Canada

    Guidance Document: Questions and Answers: Plain Language Labelling Regulations for Non-prescription Drugs

    Health Canada | Santé CanadaUpdated 7 Jul 2021

    This document provides information for industry on how Health Canada's Health Products and Food Branch interprets and …

    • HTML
  20. Open Government Canada

    Structure and Content of Clinical Study Reports ICH Topic E3: Guidance for industry

    Health Canada | Santé CanadaUpdated 29 Dec 2023

    The objective of this guidance document is to allow the compilation of a single core clinical study report …

    • HTML
“Guidance document for industry” datasets · Open Data Finder